Purchasing shares of Immunic, Inc., which trades on the Nasdaq market under the ticker symbol IMUX, involves opening and funding a brokerage account with an online stock trading platform or financial advisory firm that provides access to U.S. equities. After funding the account, investors search for the ticker symbol IMUX, review current market ask prices, and execute standard buy orders during regular trading hours. Due to the high volatility, binary clinical trial risks, and capital restructuring events typical of clinical-stage biotechnology enterprises, thorough research is strongly recommended before transacting.